Results 151 to 160 of about 18,054 (205)

Long-term outcomes in <i>FLT3</i>-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor. [PDF]

Haematologica
Short NJ, Loghavi S, Yilmaz M, Karrar O, Kim K, Dinardo CD, Kadia TM, Maroun M, Borthakur G, Issa GC, Jabbour J, Oran B, Shpall EJ, Popat U, Patel KP, Routbort M, Konopleva M, Ravandi F, Kantarjian H, Daver N.   +19 more
europepmc   +1 more source

Ongoing TKD developments

, 2019
openaire   +1 more source

TKD Genel Merkez Konutu Nasıl Sağlandı?

Türk Kütüphaneciliği, 2013
openaire   +1 more source

Molecular abnormalities and clinical features in adult patients with acute myeloid leukemia in Thailand. [PDF]

Diagn Pathol
Chantrathammachart P, Jinawath A, Puavilai T, Arsa L, Police P, Noikongdee P, Phojanasenee T, Sae-Lim P, Piyajaroenkij T, Choksomnuk P, Chuncharunee S, Niparuck P.   +11 more
europepmc   +1 more source

TKD XIII. Dönem Denetleme Kurulu Raporu

Türk Kütüphaneciliği, 2014
openaire   +1 more source

Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data. [PDF]

Blood Cancer J
Chang YS, Tien FM, Wang YW, Yao CY, Tsai XC, Ni SC, Lo MY, Lee WH, Lin CC, Kuo YY, Peng YL, Tseng MH, Ko BS, Yao M, Tien HF, Hou HA, Chou WC.   +16 more
europepmc   +1 more source

TKD characterization of low dimensional materials

, 2018
Bastos S. Fanta, Alice, Alekseeva, Svetlana, Langhammer, C., Viazmitinov, Dmitrii, Kasama, Takeshi, Semenova, Elizaveta, Burrows, Andrew   +6 more
openaire   +1 more source

Mechanism of and research progress on alterations in the RET gene in thyroid cancer (Review). [PDF]

Mol Med Rep
Wei M, Wang R, Qian J, Fang Q, Tao J.
europepmc   +1 more source

TKD GENEL MERKEZ YÖNETİM KURULUNDAKİ DEĞİŞİKLİK

Türk Kütüphaneciliği, 1963
openaire   +1 more source

Counter-Therapeutic Strategies for Resistance of FLT3 Inhibitors in Acute Myeloid Leukemia. [PDF]

Cells
Song MK.
europepmc   +1 more source